Paul -
Just waiting for something to talk about - like THIS:
Related Quotes
PRLN
0.687500
+0.031250
delayed 20 mins - disclaimer
Wednesday January 13, 10:25 am Eastern Time
Company Press Release
SOURCE: Paracelsian Inc.
Paracelsian Announces Confirmation of Anti-Cancer Effects of Herbal Extracts
ITHACA, N.Y., Jan. 13 /PRNewswire/ -- Paracelsian Inc. (OTC Bulletin Board: PRLN - news) announced today the completion of testing of four potential anti-cancer drug agents in cell culture systems at Roswell Park Cancer Institute in Buffalo, New York. All four samples, including the compound Andrographolide for which Paracelsian has a U.S. Patent Pending, demonstrated significant anti-cancer activity against a human breast cancer cell line. The samples were selected from Paracelsian's extensive library of nearly 2,800 Traditional Chinese Medicines.
While all four samples demonstrated anti-cancer activity, Andrographolide and two other samples were more active than the well known anti-cancer drug Paclitaxel in the same assay. In addition, Andrographolide and two other samples exhibited strong potential as effective agents against multi-drug resistant tumors.
The three most active samples are currently being tested at the Southern Research Institute for in vivo (live) anti-tumor activity against human breast cancer and prostate cancer tumors implanted in mice. Results of this testing are expected in the Spring. Further testing of all four samples, focusing on inhibiting tumor growth and angiogenesis, is planned at Roswell Park in the immediate future.
''This study conducted at Roswell Park represents important validation of our internal testing of these four samples,'' said Bernie Landes, the Company's President and CEO. ''The level of anti-cancer activity demonstrated by three of the samples was especially intriguing,'' continued Mr. Landes. ''We are very excited with these results. We look forward to continued testing of these samples and others from our extensive library at the Southern Research Institute and Roswell Park as part of a more aggressive program of drug discovery and development,'' added Mr. Landes.
Paracelsian is a unique biotechnology company whose business centers on the development and application of functional bioassays. These assays are used for Quality Assurance of herbs, botanicals and other dietary supplements, in the development of dietary supplement, OTC and pharmaceutical products, and in monitoring environmental toxins and identifying carcinogens. Notice: This news release may contain forward-looking statements.
|
